| Stage | OPLN | % of rev | CVNA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $555M | 100.00% | $8.0B | 100.00% | CVNA ×14.50 |
| Gross profit | $239M | 43.15% | $1.5B | 18.92% | OPLN +24.2pp |
| Operating income | $68M | 12.17% | $714M | 8.88% | OPLN +3.3pp |
| Pre-tax income | $61M | 11.02% | $552M | 6.87% | OPLN +4.2pp |
| Net income | $44M | 7.99% | $483M | 6.01% | OPLN +2.0pp |
| Stage | OPLN | CVNA | Gap · A − B |
|---|---|---|---|
| Revenue | $555M100.00% | $8.0B100.00% | CVNA ×14.50 |
| Gross profit | 43.15%$239M | 18.92%$1.5B | OPLN +24.2pp |
| Operating income | 12.17%$68M | 8.88%$714M | OPLN +3.3pp |
| Pre-tax income | 11.02%$61M | 6.87%$552M | OPLN +4.2pp |
| Net income |
| 7.99%$44M |
| 6.01%$483M |
| OPLN +2.0pp |
No shared counterparties.